Nova Patents
NO20021638L

Fab i inhibitors

Abstract

The open-style of invention (I) compounds or salts of its medicinal, it is FabI inhibitor, used to treat bacterial infections. In by in type in the, (a,) is (a), and (b), and (c), and (d), and (e), and (f), and (g), and (h), and (I), and (j), and (k), and (l), and (m), and (n), and (o) or (p); (I) in the R1 is h or C1-4 alkyl; R2 is h, and C1-4 alkyl or C3-6 ring alkyl; R3 is (q), and (r), and (s), and (t), and (u), and (v) or (w); R4 is h or C1-4 alkyl; (x) Said two a specified of key one of is double bond, another is single; Dang with connection of key is double bond Shi R5 is CH2, or Dang with connection of key is single Shi R5 is h or C1-4 alkyl; R6 is h or C1-4 alkyl; R7 is h or C1-6 alkyl or-C0-6 alkyl-Ar;Y is h, and C1-4 alkyl, and n (R') 2, and NHC (O) R', and NHCH2C (O) R' or NHC (O) CH=CHR'; each x respectively is h, and C1-4 alkyl, and CH2OH, and OR', and SR', and CN, and n (R') 2, and CH2N (R') 2, and NO2, and CF3, and CO2R', and CON (R') 2, and COR', and NR'C (O) R', and f, and Cl, and Br, and I or-s (O) rCF3;W is s or O;Q is h or C1-4 alkyl; m is CH2 or O;L is CH2 or c (O); e is o or NR'; each R' respectively is h, and C1-6 alkyl or-C0-6 alkyl-Ar ; And r is 0, 1, or 2.

NO20021638L, drawing sheet 1
Sheet 1 of 1

Term

No projected expiry on record.

  1. Priority
  2. Filed
  3. Published
  4. Today

1 claim: 1 independent, 0 dependent

  1. 1
    <Our <Our